[HTML][HTML] … IFCT-0803 study, a phase II study of cetuximab, pemetrexed, cisplatin, and concurrent radiotherapy in patients with locally advanced, unresectable, stage III …
… administered at the same schedules for maximally three cycles, with … Six phase II trials have
tested cetuximab combined with radiation therapy, with or without chemotherapy, for stage III …
tested cetuximab combined with radiation therapy, with or without chemotherapy, for stage III …
[HTML][HTML] … 56-Gy simultaneous integrated boost intensity-modulated radiation therapy for locally advanced squamous cell carcinoma of the head and neck, an intergroup …
…, Japan Clinical Oncology Group Radiation Therapy … - BMC cancer, 2023 - Springer
… schedule and prescription, and the use of concurrent chemotherapy. … , two-arm, open-label,
randomized phase III study. The study protocol was reviewed by the Japan Clinical Oncology …
randomized phase III study. The study protocol was reviewed by the Japan Clinical Oncology …
… once-daily compared with twice-daily thoracic radiation therapy concurrently with etoposide and cisplatin in limited-stage small cell lung cancer: A multicenter, phase II …
B Qiu, QW Li, JL Liu, Y Huang, QS Pang, ZF Zhu… - … of Radiation Oncology …, 2021 - Elsevier
… radiation pneumonitis were observed in 19% and 2% of patients, respectively, with both rates
lower than those seen in the Intergroup … about the best radiation schedule will increase in …
lower than those seen in the Intergroup … about the best radiation schedule will increase in …
[HTML][HTML] … of Radiation Therapy Treatment Plans in a Randomized Phase 2 Trial Comparing 2 Schedules of Twice-Daily Thoracic Radiation Therapy in Limited Stage …
… thoracic radiation therapy (TRT) concurrently with chemotherapy in limited-stage small cell
lung cancer. We reviewed radiation therapy treatment plans in a randomized phase 2 trial …
lung cancer. We reviewed radiation therapy treatment plans in a randomized phase 2 trial …
[HTML][HTML] Bone marrow-sparing IMRT in anal cancer patients undergoing concurrent chemo-radiation: Results of the first phase of a prospective phase II trial
F Arcadipane, P Silvetti, F Olivero, A Gastino… - Cancers, 2020 - mdpi.com
… functional imaging with 18-Fluoro-2-deoxy-glucose positron emission … radiation delivery
via intensity-modulated radiotherapy (IMRT). We investigated, within a prospective phase II trial, …
via intensity-modulated radiotherapy (IMRT). We investigated, within a prospective phase II trial, …
Long-Term Follow-Up Analysis of NRG Oncology RTOG 0415: A Randomized Phase III Non-Inferiority Study Comparing Two Fractionation Schedules in Patients with …
… -randomized, intergroup multi-institutional phase II study was … through the Trans Tasman
Radiation Oncology Group (TROG… No previous or concurrent androgen withdrawal therapy was …
Radiation Oncology Group (TROG… No previous or concurrent androgen withdrawal therapy was …
[HTML][HTML] … 3 weeks concurrently with radiotherapy in the treatment of locally advanced head and neck squamous cell carcinomas: what is the best dosing and schedule …
K Mashhour, W Hashem - Asian Pacific journal of cancer …, 2020 - ncbi.nlm.nih.gov
… scheduling of cisplatin concurrently with radiation therapy … schedule and dose of weekly
cisplatin is variable in different clinics and centers. A phase three trial using cisplatin 20mg/m 2 …
cisplatin is variable in different clinics and centers. A phase three trial using cisplatin 20mg/m 2 …
[HTML][HTML] Concurrent chemoradiation in anal cancer patients delivered with bone marrow-sparing IMRT: Final results of a prospective phase II trial
F Arcadipane, P Silvetti, F Olivero, A Gastino… - Journal of Personalized …, 2021 - mdpi.com
… , eventually hampering treatment compliance [4]. When radiation therapy is delivered with
… of successful trial (p1) with the treatment schedule under investigation (BM-sparing IMRT) …
… of successful trial (p1) with the treatment schedule under investigation (BM-sparing IMRT) …
High-dose once-daily thoracic radiotherapy in limited-stage small-cell lung cancer: CALGB 30610 (Alliance)/RTOG 0538
J Bogart, X Wang, G Masters, J Gao… - … of Clinical Oncology, 2023 - ingentaconnect.com
… concurrent chemotherapy were safe and effective.Two additional large multi-institutional
phase III … use of high-dose once-daily radiotherapy, both CONVERT and our study could justify …
phase III … use of high-dose once-daily radiotherapy, both CONVERT and our study could justify …
Phase III randomized study of induction chemotherapy followed by definitive radiotherapy+ cetuximab versus chemoradiotherapy in squamous cell carcinoma of head …
MC Merlano, N Denaro, S Vecchio, L Licitra, P Curcio… - Oncology, 2020 - karger.com
… with the same RT scheduling. Due to slow accrual and incomplete data … Compliance with
radiation treatment … study, while standard treatment (Arm B) consisted of concurrent carboplatin …
radiation treatment … study, while standard treatment (Arm B) consisted of concurrent carboplatin …